Publicaciones en colaboración con investigadores/as de Hospital Universitario La Paz (93)

2023

  1. The Prognostic Significance of Tumor-Infiltrating Lymphocytes, PD-L1, BRCA Mutation Status and Tumor Mutational Burden in Early-Stage High-Grade Serous Ovarian Carcinoma-A Study by the Spanish Group for Ovarian Cancer Research (GEICO)

    International journal of molecular sciences, Vol. 24, Núm. 13

2022

  1. Laboratory Cross-Comparison and Ring Test Trial for Tumor BRCA Testing in a Multicenter Epithelial Ovarian Cancer Series: The BORNEO GEICO 60-0 Study

    Journal of Personalized Medicine, Vol. 12, Núm. 11

  2. The Clonal Relationship Between the Ductal and Lobular Components of Mixed Ductal-Lobular Carcinomas Suggested a Ductal Origin in Most Tumors

    American Journal of Surgical Pathology, Vol. 46, Núm. 11, pp. 1545-1553

2020

  1. The Frequency and Prognostic Significance of the Histologic Type in Early-stage Ovarian Carcinoma: A Reclassification Study by the Spanish Group for Ovarian Cancer Research (GEICO)

    American Journal of Surgical Pathology, Vol. 44, Núm. 2, pp. 149-161

2018

  1. Erratum to: Recommendations for biomarker testing in epithelial ovarian cancer: a National Consensus Statement by the Spanish Society of Pathology and the Spanish Society of Medical Oncology (Clinical and Translational Oncology, (2018), 20, 3, (274-285), 10.1007/s12094-017-1719-x)

    Clinical and Translational Oncology

  2. Recommendations for biomarker testing in epithelial ovarian cancer. A national consensus statement by the Spanish Society of Pathology and the Spanish Society of Medical Oncology

    Revista Espanola de Patologia

  3. Recommendations for biomarker testing in epithelial ovarian cancer: a National Consensus Statement by the Spanish Society of Pathology and the Spanish Society of Medical Oncology

    Clinical and Translational Oncology, Vol. 20, Núm. 3, pp. 274-285

2017

  1. Neoadjuvant therapy with weekly nanoparticle albumin-bound paclitaxel for luminal early breast cancer patients: Results from the nabrax study (GEICAM/2011-02), a multicenter, non-randomized, phase ii trial, with a companion biomarker analysis

    Oncologist, Vol. 22, Núm. 11, pp. 1301-1308

2016

  1. Autoregulatory loop of nuclear corepressor 1 expression controls invasion, tumor growth, and metastasis

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 113, Núm. 3, pp. E328-E337

2013

  1. DICER1, DROSHA and miRNAs in patients with non-small cell lung cancer: Implications for outcomes and histologic classification

    Carcinogenesis, Vol. 34, Núm. 5, pp. 1031-1038

  2. GEICO (Spanish Group for Investigation on Ovarian Cancer) treatment guidelines in ovarian cancer 2012

    Clinical and Translational Oncology, Vol. 15, Núm. 7, pp. 509-525

2011

  1. Lysyl oxidase-like 2 (LOXL2), a new regulator of cell polarity required for metastatic dissemination of basal-like breast carcinomas

    EMBO Molecular Medicine, Vol. 3, Núm. 9, pp. 528-544

2009

  1. Aurora kinases as prognostic biomarkers in ovarian carcinoma

    Human Pathology, Vol. 40, Núm. 5, pp. 631-638

  2. Tiling path genomic profiling of grade 3 invasive ductal breast cancers

    Clinical Cancer Research, Vol. 15, Núm. 8, pp. 2711-2722

2008

  1. Angiogenesis-related gene expression profile with independent prognostic value in advanced ovarian carcinoma

    PLoS ONE, Vol. 3, Núm. 12

  2. Clinicopathological and molecular analysis of endometrial carcinoma associated with tamoxifen

    Modern Pathology, Vol. 21, Núm. 8, pp. 925-936

  3. Epithelial-mesenchymal transition in breast cancer relates to the basal-like phenotype

    Cancer Research, Vol. 68, Núm. 4, pp. 989-997

  4. Molecular profiling pleomorphic lobular carcinomas of the breast: Evidence for a common molecular genetic pathway with classic lobular carcinomas

    Journal of Pathology, Vol. 215, Núm. 3, pp. 231-244

2007

  1. Inactivation of the candidate tumor suppressor Par-4 in endometrial cancer

    Cancer Research, Vol. 67, Núm. 5, pp. 1927-1934

  2. Sox2: A possible driver of the basal-like phenotype in sporadic breast cancer

    Modern Pathology, Vol. 20, Núm. 4, pp. 474-481